AGC Pharma Chemicals Validates Facilities for CDMO Services via Scientist.com’s VERIF.i® Program
1.7.2026 13:55:00 CEST | Business Wire | Press release
Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform and digital marketplace, and AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) for small molecule API and HPAPI, announced today that AGC has successfully completed an onsite assessment of its new Barcelona facility using the VERIF.i® supplier pre-assessment program.
The newly expanded Barcelona site strengthens AGC’s position as a global leader in the development and commercialization of complex small molecule Active Pharmaceutical Ingredients (APIs) and highly potent APIs (HPAPIs). Designed for maximum flexibility, safety, and energy efficiency, the facility expands AGC’s end-to-end capabilities from gram-scale to ton-scale production under the highest quality and sustainability standards.
“At AGC Pharma Chemicals, we place the highest priority on the integrity of our operational processes and the expertise of our frontline teams,” said Jun Kurihara, CEO of AGC Pharma Chemicals. “By leveraging VERIF.i to demonstrate our adherence to international management standards and the robustness of our production oversight, we reinforce our transparent and unwavering commitment to quality for our customers.”
VERIF.i was developed to provide suppliers of regulated research services—including chemistry, manufacturing, and controls (CMC)—with a platform to proactively communicate their capabilities against established industry criteria. These onsite pre-assessments are conducted by independent, third-party auditors to ensure the integrity and objectivity of the site visit.
“When sourcing regulated services with high reputational risk, resource-intensive onsite pre-assessments are a critical component of the due diligence process,” stated Matt McLoughlin, SVP of Compliance & Categories at Scientist.com. “VERIF.i creates a standardized process that addresses these barriers for both sides, saving time and resources while allowing high-caliber suppliers like AGC Pharma Chemicals to differentiate themselves through independent, actionable insights into their facilities and personnel.”
The program helps pharmaceutical and biotech customers accelerate the procurement of regulated services with increased confidence and reduced risk. VERIF.i is an expansion of Scientist.com’s award-winning COMPLi® solution.
For more information, please visit https://www.scientist.com/platform/regulatory-compliance
About AGC Pharma Chemicals
AGC Pharma Chemicals is a global CDMO specializing in Active Pharmaceutical Ingredients (APIs) and intermediates with facilities in Spain (Barcelona) and Japan. The company is dedicated to providing reliable execution, high-quality standards, and scalable support for small molecule API programs, guiding customers from initial development through to commercialization. Learn more at https://www.agcpharmachemicals.com/.
About Scientist.com
Scientist.com is the leading AI-enabled R&D orchestration platform and online marketplace for the life science industry. The platform simplifies drug discovery and clinical development by:
- Streamlining procurement of complex research services and materials
- Accelerating innovation through faster vendor discovery, competitive bidding and standardized workflows
- Ensuring regulatory and policy compliance via integrated pre-project reviews and oversight
- Connecting scientists with a global network of pre-qualified suppliers that provide highly specialized scientific capabilities, technologies and data assets
Scientist.com powers secure, private marketplaces for many of the world's largest pharmaceutical companies and hundreds of biotech firms, helping them digitize and harmonize outsourced R&D across discovery, preclinical, translational and clinical research. The company is headquartered in Solana Beach, California, with team members supporting customers and suppliers worldwide. For more information, please visit www.scientist.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260701034608/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SamanTree Medical’s Histolog® Scanner Technology Featured in 13 Publications in Special BJU International Issue on Confocal Microscopy in Urology1.7.2026 15:01:00 CEST | Press release
Papers highlight clinical research on use of confocal microscopy for real-time tissue assessment in various urologic procedures SamanTree Medical, a global leader in surgical imaging innovation, today announced that Histolog Scanner confocal microscopy technology has been featured in 13 peer-reviewed clinical papers in a special issue of BJU International, one of the world’s leading journals in urology. The special edition focuses on a growing body of evidence of the role of confocal microscopy in urologic surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701425845/en/ SamanTree Medical announces that Histolog® Scanner confocal microscopy technology is featured in 13 peer-reviewed clinical papers in a special issue of BJU International. “The special issue represents increasing momentum behind confocal microscopy in urologic surgery,” said Professor Greg Shaw, consultant urologic surgeon at University College London
Regnology to Acquire Fed Reporter, Accelerating U.S. Leadership and Advancing Regulatory Modernization1.7.2026 15:00:00 CEST | Press release
Deal establishes Regnology as a central partner in U.S. regulatory modernization, extending reach to over 4,000 financial institutions Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced it has entered into a definitive agreement to acquire Fed Reporter, the market-leading U.S. provider of regulatory reporting solutions for financial institutions of all sizes, including banks, credit unions, and bank holding companies. The acquisition marks a pivotal milestone in Regnology’s U.S. expansion, creating the most comprehensive regulatory reporting coverage across the American financial landscape and extending its reach to more than 4,000 institutions from global banks to community lenders. By combining a proven, cloud-first, agentic-first technology foundation with deeply embedded local expertise, Regnology is uniquely positioned to support more efficient, transparent, and data-driven reporting, while strengthening alignment bet
Xsolla Announces Scholarship Program to Support Emerging Developers1.7.2026 15:00:00 CEST | Press release
New Initiative Expands Access To Gamescom By Reducing Financial Barriers For Independent And Mid-Tier Game Developers Worldwide Xsolla, a leading global video game commerce company, today announced the launch of the Xsolla Developer Scholarship Program - Cologne 2026 an initiative designed to support independent and mid-tier game developers who face financial barriers to attending gamescom 2026 in Cologne, Germany. As the world’s largest gaming event, gamescom brings together developers, publishers, investors, and industry leaders from across the globe to explore new opportunities, showcase innovative projects, and build meaningful business relationships. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701200418/en/ Graphic: Xsolla The developer scholarship program is designed to help promising studios and independent creators gain access to one of the industry’s most influential events by providing professional developmen
Introducing Arbex: a New Global Leader in Tissue and Hygiene1.7.2026 13:37:00 CEST | Press release
$3.4 billion joint venture between Suzano and Kimberly-Clark launches independent operations and reveals key corporate details Upon launch, Arbex becomes one of the world’s largest tissue and hygiene businesses, operating across more than 70 markets on five continents, with its headquarters in the Netherlands and an operational office in London. The company will produce and sell leading global and regional brands including Kleenex®, Scott®, Cottonelle®, Andrex®, and Viva®, with 22 manufacturing sites in 14 countries. Ehab Abou-Oaf, previously President of International Family Care & Professional at Kimberly-Clark, will directly transition in as Arbex’s CEO, with the role to be based in the United Kingdom alongside the majority of the global executive team. Arbex, a new global leader in tissue and hygiene, today commences operations as an independent business and unveils details of its brand, leadership team, and company structure. Announced in June 2025 as a $3.4 billion joint venture
Klarna has received a favorable ruling in PriceRunner litigation, awarding damages of $1.97 billion1.7.2026 13:19:00 CEST | Press release
Klarna Group plc (NYSE: KLAR) today announces that the court has ruled in PriceRunner’s favor, awarding $1.97 billion in damages in an antitrust case brought by PriceRunner against Google. The award compensates for lost revenue caused by Google's preferential treatment of its own comparison-shopping service over independent price-comparison services, conduct that also drives up costs for consumers. "When markets work well, everyone benefits. Consumers get higher quality at lower cost, companies stay focused on serving customers rather than defending position, and society is better off for it. This ruling supports a healthier, more competitive market for the way people compare products and services — and that is good for everyone who shops," said Dan Greaves, Head of Communications and Policy, Klarna. Klarna acquired PriceRunner in 2022 to add rich product discovery, price comparisons, and product reviews to the Klarna app, and drive high-intent traffic to retail partners. Klarna has si
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom